Ginwa Enterprise (Group) Inc. (SHA:600080)

China flag China · Delayed Price · Currency is CNY
7.62
-0.40 (-4.99%)
Apr 30, 2026, 2:56 PM CST
7.02%
Market Cap 2.69B
Revenue (ttm) 544.04M
Net Income (ttm) 15.58M
Shares Out 352.71M
EPS (ttm) 0.04
PE Ratio 172.40
Forward PE n/a
Dividend 0.03 (0.37%)
Ex-Dividend Date n/a
Volume 164,000
Average Volume 10,312,244
Open 7.62
Previous Close 8.02
Day's Range 7.62 - 7.62
52-Week Range 6.71 - 9.35
Beta 0.41
RSI 43.51
Earnings Date Apr 29, 2026

About Ginwa Enterprise (Group)

Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also involved in the pharmaceutical logistics activities. The company was founded in 1996 and is headquartered in Xi'an, China. [Read more]

Sector Healthcare
Founded 1996
Employees 588
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600080
Full Company Profile

Financial Performance

In 2025, Ginwa Enterprise (Group)'s revenue was 544.04 million, a decrease of -7.07% compared to the previous year's 585.46 million. Earnings were 15.58 million, a decrease of -79.12%.

Financial Statements

News

There is no news available yet.